Product

LCIG

Aliases

(Levodopa-Carbidopa Intestinal Gel)

1 clinical trial

1 indication

Indication

Parkinson's Disease

Clinical trial

1) To Identify the Concentration of CD That Provides Optimal Bioavailability of a Concomitant Fixed Concentration of LD Infused SC Continuously; 2) To Compare the Bioavailability of the Optimal LD/CD Solution to That of LD/CD Intestinal Gel

Status: Completed, Estimated PCD: 2016-06-30